CSF3 and infection: Granulocyte colony-stimulating factor (G-CSF) was used in 55.7% (n = 30), IgG replacement therapy (IgGRT) in 53.7% (n = 29) and antibiotic prophylaxis in 38.9% (n = 23) to reduce susceptibility to infections (Fig. 4A).